Gene: ANKRD33B
Official Full Name: ankyrin repeat domain 33Bprovided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19843 | ANKRD33B Knockout cell line (HeLa) | Human | ANKRD33B | 1:3~1:6 | Negative | Online Inquiry |
KO19844 | ANKRD33B Knockout cell line (HCT 116) | Human | ANKRD33B | 1:2~1:4 | Negative | Online Inquiry |
KO19845 | ANKRD33B Knockout cell line (HEK293) | Human | ANKRD33B | 1:3~1:6 | Negative | Online Inquiry |
KO19846 | ANKRD33B Knockout cell line (A549) | Human | ANKRD33B | 1:3~1:4 | Negative | Online Inquiry |
ANKRD33B Gene Knockout Cell Lines are specialized, genetically modified cell lines designed to facilitate in-depth studies of the function and regulation of the ANKRD33B gene. This gene plays a crucial role in various biological processes, including immune regulation and signal transduction. By employing advanced CRISPR/Cas9 gene editing techniques, these knockout cell lines effectively eliminate the expression of ANKRD33B, providing a valuable tool for researchers to decipher its functional contributions in both physiological and pathological contexts.
The key mechanism behind these knockout cell lines lies in their ability to provide a clean genetic background, allowing for the assessment of how the absence of the ANKRD33B gene influences cellular behavior, signaling pathways, and overall gene expression profiles. Researchers can utilize these models to explore phenomena such as immune response variations and the impact of ANKRD33B on disease states, making them indispensable in both preclinical and clinical research applications.
The scientific importance of ANKRD33B Gene Knockout Cell Lines is underscored by their potential to elucidate novel therapeutic targets and inform drug discovery efforts. This is especially pertinent given the rising interest in targeted therapies for autoimmune diseases and cancer, where immune regulation is pivotal.
Compared to traditional cell lines, these knockout models provide enhanced specificity and reproducibility in experiments aimed at studying gene function. Unlike alternatives that may exhibit off-target effects or confounding variables, the precise knockout of ANKRD33B ensures that researchers can draw clearer conclusions regarding its biological role.
For researchers and clinicians looking to advance their understanding of genetic contributions to disease, ANKRD33B Gene Knockout Cell Lines offer a unique opportunity. These lines not only enrich the available toolkit for genetic studies but also serve as a bridge toward developing innovative therapeutic strategies.
With years of experience in biological product development, our company is dedicated to providing high-quality, cutting-edge research tools that empower scientists worldwide to push the boundaries of discovery. We believe that advancing your research requires the right tools, and our ANKRD33B Gene Knockout Cell Lines are expertly crafted to meet those needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.